PSTI

Pluristem Therapeutics Inc
1.00
0.00 (0.00%)

Pluristem Therapeutics Inc. (PSTI) Fundamentals

Pluristem Therapeutics Inc is a US-based company that acts as a developer of placenta-based cell therapy product candidates for the treatment of multiple ischemic, inflammatory, and hematologic conditions. The lead indications are critical limb ischemia, recovery after surgery for femoral neck fracture, and acute radiation syndrome. The company operations are focused on the research, development, clinical trials, and manufacturing of cell therapeutics and related technologies.
SHARE INFORMATION
Market Cap$ 33,318,012
Shares Outstanding32,347,584
Float30,621,835
Percent Float94.66%
Short Interest0.00
Short Percent Float0.0%
Short Interest Ratio0.00
Short Interest Date-
Latest Fiscal Dividend Per Share$ 0.00
Latest Fiscal Revenue$ 0
Latest Fiscal EPS$ -1.76
Latest Fiscal Date2021-06-30
DIVIDENDS
Dividend (3 Years)$ 0.00
Dividend (5 Years)$ 0.00
Ex Dividend Date-
Dividend Rate$ 0.00
Dividend Yield0.0%
Payment Cash-
HOLDERS
Institutions92
Institutional Holdings Date2022-06-30
Institutional Bought Previous 3 Months248,818
Institutional Holdings Percent9.7%
Institutional Sold Previous 3 Months1,477,850
Insider Holdings Date2022-06-30
Insider Bought Previous 3 Months-
Insider Holdings Percent25.0
Insider Sold Previous 3 Months-
Insider Shares Owned8,075,933
TRADING INFO
52 Week High$ 3.68
52 Week Low$ 1.00
52 Week High Change$ -70.74
21 Day Moving Average$ 1.1787
21 Day Extended Moving Average$ 1.152
50 Day Moving Average$ 1.282
50 Day Extended Moving Average$ 1.2946
200 Day Moving Average$ 1.8735
200 Day Extended Moving Average$ 2.0321
10 Day Average Volume109,652
20 Day Average Volume82,948
30 Day Average Volume80,184
50 Day Average Volume111,901
Alpha-0.031967
Beta1.9123
Standard Deviation0.250495
R20.139266
7 Day Price Change$ 0.00
7 Day Percent Change0.0%
21 Day Price Change$ -0.23
21 Day Percent Change-18.25%
30 Day Price Change$ -0.26
30 Day Percent Change-20.16%
Month to Date Price Change$ -0.20
Month to Date Percent Change-16.26%
Quarter to Date Price Change$ -0.20
Quarter to Date Percent Change-16.26%
180 Day Price Change$ -0.65
180 Day Percent Change-38.69%
200 Day Price Change$ -0.48
200 Day Percent Change-31.79%
Year to Date Price Change$ -0.43
Year to Date Percent Change-29.45%

Pluristem Therapeutics Inc. (PSTI) Key Ratios

PROFITABILITY
EBIT Margin-19,776.5%
EBITDA Margin-19,241.9%
Pre-Tax Profit Margin0.0%
Profit Margin Count0.0%
Gross Margin100.0%
Profit Margin TOT0.0%
INCOME STATEMENTS
Revenue$ 234,000
Revenue Per Share$ 0.0072
Revenue (3 Years)$ 0.00
Revenue (5 Years)$ 0.00
FINANCIAL STRENGTH
Price to Tangible Book0.90
Total Debt To Equity0.80
Int Coverage-79.70
Current Ratio8.20
Leverage Ratio1.90
Quick Ratio7.90
Long Term Debt To Capital0.44
VALUATION MEASURES
PE Ratio-0.70
Enterprise Value$ 2,202,011
Price to Sales142.3847
Price to Free Cash-1.20
PE High Last 5 Years-4.60
Price To Book0.90
Price To Cash Flow0.00
PE Low Last 5 Years-3.60
Price to Tangible Book0.90
MANAGEMENT EFFECTIVENESS
Receivables Turnover0.30
Invoice Turnover0.00
Assets Turnover0.00
Return Assets-60.83
Return on Equity-91.39
Return on Capital-67.93

Pluristem Therapeutics Inc. (PSTI) Profile

PROFILE INFO
Issue TypeCS
SEC TypeEQS
AuditorKesselman & Kesselman C.P.A.s
CEOYaky Yanay
Emplyoees162
Last AuditUQ
CIK0001158780
IndustryBiotechnology
SectorHealthcare
NAICSBiological Product (except Diagnostic) Manufacturing(325414)
CONTACT INFO
AddressMATAM Advanced Technology Park
Building No.5
Haifa, 3508409
Websitehttps://www.pluristem.com
Facsimile+972 747108787
Telephone+972 747108600
Emailefratk@pluristem.com


Your Recent History
NASDAQ
PSTI
Pluristem ..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to InvestorsHub
Register Now

NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.